Yale SPORE in Lung Cancer News
Blood tests looking for cancer markers have been around for decades, but the latest generation of tests hunt for tiny fragments of an individual cancer’s DNA in a person’s blood. These tumor-informed tests are a striking advance in what’s known as circulating tumor DNA (ctDNA) analysis, and researchers at Yale are
already seeing intriguing results. The goal is to personalize cancer treatment for individual patients. “The technology is exciting because we can monitor outcomes in real time and determine who needs more or
less treatment,” says Roy Herbst, deputy director of the Yale Cancer Center.
- June 06, 2025
Researchers from Yale Cancer Center participated in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30 to June 3, where they presented the latest research advancements from Yale Cancer Center and Smilow Cancer Hospital.
- June 02, 2025Source: healthbook (with Dr. Roy Herbst)
Dr. Roy Herbst, deputy director of Yale Cancer Center and chief of medical oncology/hematology, provides his highlights on new lung cancer research presented at the 2025 ASCO Annual Meeting.
- June 01, 2025Source: YaleMedicine
After being diagnosed with lung cancer, a journalist chronicles how advanced cancer treatments are saving his life.
- May 26, 2025
In honor of National Cancer Research Month, Dr. Katerina Politi shares why her research is focused on cancer.
- May 23, 2025
The Rimm Lab at Yale Pathology, under the direction of David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and professor of medicine (medical oncology), marks 30 years of research, innovation, and training.
- May 22, 2025
Yale Cancer Center joined Hill Day, hosted by the American Association for Cancer Research (AACR) and the Association of American Cancer Institutes (AACI) to bring cancer center directors, researchers, physician-scientists, cancer survivors, and other advocates together to build support for a strong federal investment in biomedical research—and cancer research in particular—through the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Hill Day is a special opportunity in that it helps members of cancer centers secure time to meet with their Congressional representatives to share the importance and impact of cancer funding.
- May 21, 2025
Several Department of Pathology faculty members were among more than 100 Yale physicians recognized as top doctors in Connecticut by Connecticut Magazine in its annual Top Doctors issue.
- May 14, 2025
Over 40 Yale Cancer Center researchers will share advances for new therapies at the 2025 ASCO Annual Meeting with research areas covering breast, lung, prostate, head and neck, early onset, and metastatic cancers.
- May 12, 2025
Publications regarding cancer attributed to first- and last-authors of published papers